Literature DB >> 2566924

Differential increases in brain levels of neuropeptide Y and vasoactive intestinal polypeptide after kainic acid-induced seizures in the rat.

J Marksteiner1, G Sperk, D Maas.   

Abstract

Changes in immunoreactivities of neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP) were investigated in the brain of rats after severe kainic acid (KA, 10 mg/kg, i.p.) induced limbic seizures. Decreased levels of both neuropeptides were observed in the frontal cortex, straitum, dorsal hippocampus and amygdala/pyriform cortex subsequently to the period of acute seizures (3 h after injection of the toxin). Then NPY increased consistently in the frontal cortex, hippocampus and amygdala/pyriform cortex. Highest levels (290% of controls) were found in the frontal cortex after two months. Anticonvulsant therapy with phenobarbital (20 mg/kg, i.p., twice daily for three weeks) partially suppressed the rise in NPY levels. Immunoreactivity of VIP increased (to 150%) in the frontal cortex only transiently 3 days after injection of kainic acid. At the subsequently examined time intervals (10-60 days after kainic acid) it declined to control values. Levels decreasing subsequently to acute seizures reflect increased release and degradation of the respective peptide. Increased NPY levels suggest "upregulation" of NPY/somatostatin/GABA neurons due to the decreased seizure threshold of the animals. The early, reversible rise of VIP in the cortex points to a short-lasting activation of this peptide system contained in local cholinergic neurons. This may be a consequence either of the acute seizures or subsequent neuropathological changes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566924     DOI: 10.1007/BF00165140

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

1.  Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold.

Authors:  J Marksteiner; G Sperk
Journal:  Neuroscience       Date:  1988-08       Impact factor: 3.590

2.  Profound suppression of kindled seizures by cysteamine: possible role of somatostatin to kindled seizures.

Authors:  T Higuchi; G S Sikand; N Kato; J A Wada; H G Friesen
Journal:  Brain Res       Date:  1983-12-12       Impact factor: 3.252

3.  Selective depletion of somatostatin in rat brain by cysteamine.

Authors:  M Palkovits; M J Brownstein; L E Eiden; M C Beinfeld; J Russell; A Arimura; S Szabo
Journal:  Brain Res       Date:  1982-05-20       Impact factor: 3.252

4.  Two types of cholinergic innervation in cortex, one co-localized with vasoactive intestinal polypeptide.

Authors:  F Eckenstein; R W Baughman
Journal:  Nature       Date:  1984 May 10-16       Impact factor: 49.962

5.  Somatostatin precursor in the rat striatum: changes after local injection of kainic acid.

Authors:  G Sperk; R Widmann
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

6.  Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin-immunoreactive material.

Authors:  P Somogyi; A J Hodgson; A D Smith; M G Nunzi; A Gorio; J Y Wu
Journal:  J Neurosci       Date:  1984-10       Impact factor: 6.167

7.  Kainic acid induced seizures: neurochemical and histopathological changes.

Authors:  G Sperk; H Lassmann; H Baran; S J Kish; F Seitelberger; O Hornykiewicz
Journal:  Neuroscience       Date:  1983-12       Impact factor: 3.590

8.  Morphology, distribution, and synaptic relations of somatostatin- and neuropeptide Y-immunoreactive neurons in rat and monkey neocortex.

Authors:  S H Hendry; E G Jones; P C Emson
Journal:  J Neurosci       Date:  1984-10       Impact factor: 6.167

9.  Somatostatin augments the spread of limbic seizures from the hippocampus.

Authors:  J B Perlin; E W Lothman; W A Geary
Journal:  Ann Neurol       Date:  1987-05       Impact factor: 10.422

10.  Changes of immunoreactive somatostatin and beta-endorphin content in rat brain after amygdaloid kindling.

Authors:  N Kato; T Higuchi; H G Friesen; J A Wada
Journal:  Life Sci       Date:  1983-05-23       Impact factor: 5.037

View more
  16 in total

1.  Differential regulation of vasoactive intestinal peptide (VIP) in the dentate gyrus and hippocampus via the NO-cGMP pathway following kainic acid-induced seizure in the rat.

Authors:  Anna Siobhan Cosgrave; Jennifer S McKay; Thimmasettappa Thippeswamy
Journal:  J Mol Neurosci       Date:  2010-04-06       Impact factor: 3.444

2.  Unbalanced Peptidergic Inhibition in Superficial Neocortex Underlies Spike and Wave Seizure Activity.

Authors:  S Hall; M Hunt; A Simon; L G Cunnington; L M Carracedo; I S Schofield; R Forsyth; R D Traub; M A Whittington
Journal:  J Neurosci       Date:  2015-06-24       Impact factor: 6.167

3.  Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals.

Authors:  M S Wyeth; N Zhang; C R Houser
Journal:  Neuroscience       Date:  2011-12-03       Impact factor: 3.590

Review 4.  Dysfunction of hippocampal interneurons in epilepsy.

Authors:  Yu-Qiang Liu; Fang Yu; Wan-Hong Liu; Xiao-Hua He; Bi-Wen Peng
Journal:  Neurosci Bull       Date:  2014-11-05       Impact factor: 5.203

5.  Changes in neuropeptide Y protein expression following photothrombotic brain infarction and epileptogenesis.

Authors:  Elena A Kharlamov; Alexander Kharlamov; Kevin M Kelly
Journal:  Brain Res       Date:  2006-11-22       Impact factor: 3.252

6.  Knock-out mice reveal a critical antiepileptic role for neuropeptide Y.

Authors:  S C Baraban; G Hollopeter; J C Erickson; P A Schwartzkroin; R D Palmiter
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

7.  Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.

Authors:  S Greber; C Schwarzer; G Sperk
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

8.  Somatostatin and neuropeptide Y neurons undergo different plasticity in parahippocampal regions in kainic acid-induced epilepsy.

Authors:  Meinrad Drexel; Elke Kirchmair; Anna Wieselthaler-Hölzl; Adrian Patrick Preidt; Günther Sperk
Journal:  J Neuropathol Exp Neurol       Date:  2012-04       Impact factor: 3.685

9.  Neuropeptide Y and Epilepsy.

Authors:  William F. Colmers; Bouchaïb El Bahh
Journal:  Epilepsy Curr       Date:  2003-03       Impact factor: 7.872

Review 10.  The neurogenic niche in Alzheimer's disease.

Authors:  Connor M Wander; Juan Song
Journal:  Neurosci Lett       Date:  2021-07-13       Impact factor: 3.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.